» Authors » Steven Levitte

Steven Levitte

Explore the profile of Steven Levitte including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 306
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Primavera R, Wang J, Buchwald P, Ganguly A, Patel S, Bettencourt L, et al.
Nano Lett . 2025 Jan; 25(3):939-950. PMID: 39791700
In this study, we designed a nanoscale platform for sustained amino acid delivery to support transplanted pancreatic islets. The platform features mesoporous silica nanoparticles (MSNPs) loaded with glutamine (G), an...
2.
Gutierrez-Becker B, Gutierrez Becker B, Fraessle S, Yao H, Luscher J, Girycki R, et al.
J Crohns Colitis . 2024 Dec; 19(1). PMID: 39657580
Background And Aims: Validated scoring methods such as the Mayo Clinic Endoscopic Subscore (MCES) evaluate ulcerative colitis (UC) severity at the worst colon segment, without considering disease extent. We present...
3.
Levitte S, Zhang K, Guevara-Tique A, Ganguly A, Dulken B, Nilkant R, et al.
Am J Transplant . 2024 Nov; PMID: 39491097
Mesenchymal stem cells are under investigation as a novel therapy to treat solid organ transplant rejection. However, significant hurdles have limited their use in humans. Mesenchymal stem cell-derived extracellular vesicles...
4.
Levitte S, Nilkant R, Jensen A, Zhang K
Hum Immunol . 2024 Oct; 85(6):111160. PMID: 39471538
Introduction: In patients with irreversible intestinal failure, intestinal transplant has become a standard treatment option. Graft failure secondary to acute or chronic cellular rejection continues to be a significant challenge...
5.
Ganguly A, Chetty S, Primavera R, Levitte S, Regmi S, Dulken B, et al.
J Transl Med . 2024 Aug; 22(1):789. PMID: 39192240
Background: Kidneys are at risk from drug-induced toxicity, with a significant proportion of acute kidney injury (AKI) linked to medications, particularly cisplatin. Existing cytoprotective drugs for cisplatin-AKI carry side effects,...
6.
Levitte S, Nilkant R, Chen S, Beadles A, Lee J, Bonham C, et al.
Transplant Direct . 2024 Aug; 10(9):e1696. PMID: 39165490
Background: Combined heart liver transplant (CHLT) continues to gain attention as a surgical treatment for patients with end-stage heart and liver disease but remains rare. We present our institutional longitudinal...
7.
Levitte S, Guevara-Tique A, Ganguly A, Syed A, Gugig R, Zhang K, et al.
Transplantation . 2024 Jul; 108(8):e202-e203. PMID: 39042371
No abstract available.
8.
Samavati S, Yarani R, Kiani S, Hoseinkhani Z, Mehrabi M, Levitte S, et al.
J Inflamm (Lond) . 2024 Jun; 21(1):20. PMID: 38867277
Autoimmune diseases are caused by an imbalance in the immune system, producing autoantibodies that cause inflammation leading to tissue damage and organ dysfunction. Systemic Lupus Erythematosus (SLE) is one of...
9.
Overbey E, Kim J, Tierney B, Park J, Houerbi N, Lucaci A, et al.
Nature . 2024 Jun; 632(8027):1145-1154. PMID: 38862028
Spaceflight induces molecular, cellular and physiological shifts in astronauts and poses myriad biomedical challenges to the human body, which are becoming increasingly relevant as more humans venture into space. Yet...
10.
Levitte S, Khan I, Iyahen V, Ziai J, Gubatan J, Sheng R, et al.
Histochem Cell Biol . 2024 May; 162(3):225-230. PMID: 38705911
Small bowel strictures remain a debilitating consequence of Crohn's disease and contribute to poor outcomes for patients. Recently, TGFβ has been identified as an important driver of intestinal fibrosis. We...